Forging a path for MedTech Innovation.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESAsia-Pacific is experiencing unprecedented growth in the medical device space, forecasting an 8 percent CAGR, reaching USD$133 billion in 2020. With devices having a much shorter life-cycle than biopharma products, speed is of the essence in the conduct of medical device trials. An effective patient recruitment and retention strategy can propel medical device trials in the right direction by addressing cultural and organizational challenges and opportunities.
The Asia-Pacific medical device market is evolving and growing quickly. Analysts tip the market to expand at 8 percent CAGR in the coming years, driving the total size from USD $88 billion in 2015 up to $133 billion in 2020 1. Along the way, Asia-Pacific will surpass the European Union and become the second largest medical device market.
Medical device growth in Asia-Pacific is underpinned by technological progress and recognition of the fact that these products create value for patients and payors. Benefitting from technological advances in fields as diverse as microelectronics and biotechnology, devices treat a fast-growing number of diseases and meet the needs of increasingly valuefocused healthcare systems.
As a result, more medical device trials than ever are taking place, both in the West and in emerging markets. As of September 2012, 9,095 medical device trials were registered on ClinicalTrials.gov 2. That number represents less than 7 percent of all studies registered on the site. Both figures have increased over the past five years. As of September 2017, 24,533 medical device trials were registered 3. This represents almost 10 percent of all trials registered on the site and a 170 percent increase in the number of studies in 2012.
This paper discusses the value that Asia-Pacific trial sites can provide, the challenges in patient recruitment and retention that sponsors may potentially face when running studies in the region, and how partnering mitigates these potential downsides.
Forging a path for MedTech Innovation.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.